Innogen  ·  Events   Past events

(Un)making pharmaceutical futures: why we need to reimagine the drug innovation process

September 8 – September 8 2008


Seminar Room 1.06
ESRC Innogen Centre
Edinburgh University
Old Surgeons' Hall
High School Yards

All welcome, no need to book


High hopes surround the role of the pharmaceutical and biotechnology industries in improving health and creating highly skilled jobs. The promise of novel drugs, and therapies based on genes and stem cells, has prompted a range of policy initiatives including public subsidies for R&D, a liberalisation of the drug approval process and a reorientation of academic and clinical research in the name of improving knowledge translation. This talk will take a critical look at these promises and the underlying assumptions that support policy and argue that they are based on a series of widely held myths about the nature of drug innovation. In particular, it will be argued that the promise of a 'biotech revolution' has been greatly overstated and that the pharmaceutical industry is far more dependent on the public sector as a source of new medicines than is commonly believed. Based on a series of interventions in UK policy debates which question these myths, I wish to explore how STS might critically engage with the making and unmaking of 'pharmaceutical futures'.,7860,en.t4.html